Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

CORRECT RX PHARMACY SERVICES, INC.

UEI: PM4MJYRA42F3CAGE: 33HH0

CORRECT RX PHARMACY SERVICES, INC. is a federal contractor, registered under UEI PM4MJYRA42F3 and CAGE code 33HH0. It has been awarded $1,601,638 across 16 federal contracts. Primary work spans Pharmacies and Drug Stores, Offices of Mental Health Practitioners (except Physicians), and Vocational Rehabilitation Services. Top awarding agencies include Court Services And Offender Supervision Agency.

Contact Information

Registration and classification details

Registration

UEI Code

PM4MJYRA42F3

CAGE Code

33HH0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

272X8WA2XS

NAICS Codes

325414Biological Product (except Diagnostic) Manufacturing
424210Drugs and Druggists' Sundries Merchant Wholesalers(Primary)
456110Pharmacies and Drug Retailers

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

CORRECT RX PHARMACY SERVICES, INC. specializes in providing comprehensive medication management and pharmacy services to government-operated correctional and offender supervision programs. Their core capabilities center on the dispensing, distribution, and clinical oversight of pharmaceuticals withi...

CORRECT RX PHARMACY SERVICES, INC. specializes in providing comprehensive medication management and pharmacy services to government-operated correctional and offender supervision programs. Their core capabilities center on the dispensing, distribution, and clinical oversight of pharmaceuticals within secure institutional environments, ensuring adherence to regulatory standards for controlled substances, formulary compliance, and patient safety protocols. The contractor delivers integrated medication services that include inventory control, prescription fulfillment, medication reconciliation, and coordination with healthcare providers to support continuity of care for supervised populations. Their technical expertise lies in pharmacy operations tailored to correctional settings, including electronic health record integration, automated dispensing systems, and compliance with DEA and state board regulations. A key differentiator is their focus on maintaining secure, audit-ready pharmaceutical workflows in high-risk, low-resource environments where clinical access is constrained. The contractor has demonstrated sustained engagement with the Court Services and Offender Supervision Agency, delivering medication services that support the health and rehabilitation objectives of individuals under community supervision. This relationship reflects a specialized niche in correctional pharmacy operations, where reliability, security, and regulatory precision are paramount. Their primary industry focus is in NAICS 446110—Pharmacies and Drug Stores—where they operate as a clinical pharmacy provider rather than a retail outlet, emphasizing institutional and non-retail pharmaceutical delivery models. This positions them uniquely within the government contracting space as a provider of pharmacy services for correctional and probationary populations. As a Women-Owned Small Business and Woman-Owned Business certified entity headquartered in Hanover, Maryland, CORRECT RX PHARMACY SERVICES, INC. leverages its small business status to serve federal and local agencies requiring diverse supplier participation. Their geographic presence supports operations in the Mid-Atlantic region, with a strategic alignment to agencies managing offender health services.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Court Services And Offender Supervision Agency$1.6M100%
Awards by NAICS
446110 - Pharmacies and Drug Stores$1.4M87.5%
621330 - Offices of Mental Health Practitioners (except Physicians)$140.0K8.7%
624310 - Vocational Rehabilitation Services$39.7K2.5%
424210 - Drugs and Druggists' Sundries Merchant Wholesalers$13.3K0.8%
325414 - Biological Product (except Diagnostic) Manufacturing$7.9K0.5%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in CORRECT RX PHARMACY SERVICES, INC.'s top NAICS codes and agencies

NAICS: 325414
New
DIBBS
TEST KIT, BACTERIA D
Solicitation # SPE2DS-26-T-310W
The contract is for the procurement of 25 units of the API 20 E test kit, designed for the identification of Enterobacteriaceae and other gram-negative rods, under the NSN 6550-01-507-3726. Each purchase group (PG) equals 25 units, and the full order consists of exactly one PG. The product must be delivered within five days of contract award, with delivery terms specified as FOB destination, and no quantity variance is permitted. Strict shelf-life requirements apply: no more than three months may have elapsed from the date of manufacture to the date of delivery, and the item has a non-extendable shelf life of 18 months, classified as a TYPE I CODE K item. The test kits require refrigerated storage between 2 and 8 degrees Celsius at all times. Packaging must comply with commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in protective containers and shipped in suitable exterior packaging to ensure safe delivery at the lowest freight rate. The product is regulated by the FDA, and the contracting official must submit a referral via EBS for confirmation, including manufacturer and part number details. The manufacturer is bioMérieux Inc with part number 20100. Technical and quality requirements are governed by the DLA Master List, and packaging, marking, and information security controls, including potential covered defense information, are mandated per applicable DLA directives. All documentation and compliance must align with the solicitation SPE2DS-26-T-310W, issued under NAICS code 325414 by the Department of Defense.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 7 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
Federal
Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)
Solicitation # 7571MN26R00026
The U.S. Department of Health and Human Services, through its Federal Occupational Health (FOH) program and the Program Support Center, is seeking a contractor to provide a nationwide, web-based ordering portal for the procurement of medications, vaccines, and medical supplies (MVMS) to support over 300 federal entities and more than one million federal employees across the United States, the District of Columbia, and U.S. Territories. The contract is structured as a firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) award with a potential five-year performance period, consisting of a 12-month base period and four 12-month option periods, plus an optional six-month extension. The primary objective is to consolidate MVMS procurement into a single, efficient, and cost-effective system, eliminating reliance on government purchase cards and unstable supply chains while enhancing FOH’s oversight capabilities. The contractor will be responsible for maintaining a secure, user-accessible portal supporting up to 250 locations, ensuring just-in-time delivery with zero minimum order quantities, and strictly adhering to unit-dose or unit-of-use packaging requirements for all products as specified in Attachment J.1, with particular emphasis on readiness for critical items in Ready-to-Administer (RTA) format. All deliveries must comply with HHS digital accessibility standards, Section 508, CDC cold chain protocols, and federal, state, and local regulations, and must be marked with full consignee details, packing slips, and appropriate hazard or temperature-sensitive labels. Proposals must be submitted in four separate electronic volumes—Technical Proposal, Business/Cost Proposal, Past Performance, and a three-minute web portal demo—via email to Chaunda.Stewart@hhs.gov by the revised deadline of August 7, 2026, at 12:00 p.m. Eastern Time, following strict formatting requirements including a 25-page limit for the technical proposal, 12-point Times New Roman font, and 1-inch margins. All submissions must be accompanied by an Excel-based pricing worksheet detailing costs for each contract line item and the cumulative total. Offerors must pass four mandatory Phase One gate criteria: regulatory licensure including State Board of Pharmacy and FDA registrations, financial capability with a current ratio between 0.8 and 1.2, verified JIT logistics capability without minimum order thresholds, and 100% availability of unit-dose/RTA packaging for critical items. Those advancing to Phase Two will be scored
Program Support Center Acq Management Svc

POSTED

about 12 hours ago

DEADLINE

in 1 day
View Details
NAICS: 424210
New
DIBBS
ALBUTEROL INHALATIO
Solicitation # SPE2DP-26-T-4470
Albuterol Inhalation Aerosol is a prescription-only medication supplied as a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, through a plastic actuator with a strap cap and built-in counter. The canister has a net weight of 8 grams and must be stored at 20° to 25°C (68° to 77°F), with allowable excursions between 15° and 30°C, following USP controlled room temperature guidelines. The inhaler must be kept with the mouthpiece down, shaken well before each use, and brought to room temperature prior to administration to ensure optimal performance. The product has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, a minimum of 15 months of shelf life must remain. It is labeled and marked in compliance with SPE2DP-26-T-4470 and Medical Marking Standard No. 1C, and is classified as a hazardous material with flammable characteristics due to its pressurized contents. The canister must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. A current Material Safety Data Sheet (MSDS) is required and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL along with a completed cover sheet. Packaging must conform to 49 CFR and ICAO regulations for hazardous materials. The NSN is 6505-01-649-7928, with a quantity of 15 units ordered under Purchase Request 7017715897, with delivery required within 20 days of award. The solicitation is governed by DLA technical and quality requirements referenced in the DLA Master List, and buyers must confirm regulatory compliance through an EBS referral to the product specialist, providing manufacturer and bidder details. The item is regulated by the FDA and falls under Defense Information potentially subject to additional reporting.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
LIDOCAINE AND PRILOCAI
Solicitation # SPE2DP-26-T-4475
The contract solicitation SPE2DP-26-T-4475 seeks the procurement of LIDOCAINE AND PRILOCAINE PERIODONTAL GEL, specifically the brand ORAQIX at a 2.5%/2.5% concentration, supplied in dental cartridges containing 1.7 grams of gel, with each package consisting of 20 individually blister-packed cartridges. Each cartridge is accompanied by a single-use sterile blunt-tipped applicator, and the product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F). The item is regulated by the FDA, classified as a prescription-only medical product, and designated as a TYPE I (CODE Q) item with a non-extendable shelf life of 36 months. Packaging and labeling must strictly conform to MIL-STD-129, the Medical Marking Standard No. 1, and the DLA Master List of Technical and Quality Requirements, which take precedence over commercial standards such as ASTM D3951. Palletization must adhere to RP001 requirements, with barcoding and traceability required for all units. The product is not classified as hazardous under FED-STD-313, so it must be commercially packaged accordingly, though it remains subject to all applicable medical and defense packaging standards. The contract specifies delivery of three packages to Seymour Johnson Air Force Base in North Carolina with a 20-day delivery lead time from the issuance of the order, FOB destination, and no variance allowed in quantity. The total contract value is $3,000 based on a single CLIN with a unit of issue of PG (Package). The item’s NSN is 6505016569640 with manufacturer part number NDC66312-0110-20 from DENTSPLY SIRONA INC. The solicitation requires full compliance with FAR and DFARS clauses including 52.223-3 for hazardous material identification, 252.204-7012 for safeguarding covered defense information, and 252.223-7001 for hazard warning labeling. Offerors must submit electronically via DIBBS with a valid UEI and CAGE code, represent their small business status, and certify compliance with employment eligibility, anti-trafficking, and cybersecurity requirements. Proposals are due by August 1
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-26-T-4479
The contract is for the procurement of a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with an SPF of 50, designed for outdoor use and meeting stringent military specifications. The product is sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. Each unit of issue consists of a package containing 24 tubes of 3 ounces each, with a total shelf life of 24 months and a minimum of 21 months remaining at the time of government receipt. Storage must occur between 15°C and 30°C in a cool, dry environment. The item is regulated by the FDA and classified as a Type I (Code M) item with a non-extendable shelf life. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection during transit. All packaging and labeling must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over commercial standards like ASTM D3951. The product must be shipped in commercial exterior containers suitable for safe delivery by common carrier via the fastest traceable means, with no use of parcel post permitted. Delivery is FOB destination with a 20-day lead time, and the sole delivery point is the USS ZUMWALT DDG 1000 at FPO AP 96693. The shipment must be palletized in accordance with DLA packaging requirements and labeled with the NSN 6505-01-657-9247 and contract line item number 7017729391. The order quantity is one package, and no variance in quantity is permitted. The procurement is issued under solicitation SPE2DP-26-T-4479, with a response deadline of August 10, 2026, and a required delivery date of August 6, 2026. Transportation and shipping protocols are governed by DLAD procedural notes C19 and C20, and all vendors must use the Vendor Shipping Module for tracking. The contracting office is part of the Department of Defense’s Medical Supply Chain, and any bid must be referred to the product specialist in EBS with manufacturer and item details for confirmation prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 325414
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (NSAIDs)The contract entails the manufacture and delivery of ISO 17034-certified analytical reference standards specifically for nonsteroidal anti-inflammatory drugs (NSAIDs) to support veterinary drug residue testing. Two certified lots—intermediate control verification (ICV) and candidate control verification (CCV)—will be produced, each containing five 1mL glass ampules sealed for stability and purity. The reference standards are to be dissolved in LC-MS grade solvents to ensure compatibility with high-performance liquid chromatography and mass spectrometry workflows. All materials must meet rigorous certification standards to guarantee accuracy, traceability, and consistency in quantitative analytical applications. The work is required to be completed under a subcontract with a response deadline of August 7, 2026, and the place of performance is designated as Denver, Colorado, with a zip code of 80225. The contracting entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, operating under NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. The deliverables are critical for laboratory quality control and regulatory compliance in animal health testing, requiring strict adherence to certification protocols and documentation without compromising sample integrity or analytical validity.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 1 day
View Details
NAICS: 325414
New
Federal
Intent to Sole Source - Endotoxin Detection System Cartridges
Solicitation # NOI-CC-OLAO-26-007979
The National Institute of Health, Clinical Center intends to sole source the purchase of proprietary endotoxin detection system cartridges from Charles River Laboratories to support the production and release of PET IND products. These cartridges are essential for bacterial endotoxin testing, ensuring all radiopharmaceuticals are pyrogen-free prior to patient administration, and are compatible only with the institution’s existing portable testing system. Due to the proprietary nature of the cartridges, no alternative suppliers can meet the technical requirements, justifying a sole source acquisition under 41 U.S.C. 253(c)(1) and FAR 6.302-1. The contract requires delivery of cartridges estimated at $22,200 by February 1, 2025, to prevent disruption in patient-ready product release; failure to meet this deadline would compromise the ability to conduct mandatory testing. A separate shipment for additional cartridges is also required by August 24, 2026, to sustain ongoing operations. This is not a request for proposal, but a notice of intent allowing other possible sources to submit capability statements by 12:00 PM Eastern Standard Time on August 7, 2026, to Valerie Gregorio at valerie.gregorio@nih.gov. All submissions received by the deadline will be evaluated, and the government retains full discretion to proceed without competition based on the responses.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 1 day
View Details